Ovagen
Status
No approved product. No FDA-approved labeling exists. Not an FDA-approved medicine. Status in Russia and other countries was not verified for this entry.
What it is
A liver-focused bioregulator peptide from Russian research.
What published research measured
A synthetic short peptide from the Khavinson programme, described by the originating group in the context of liver and digestive tissue function and protein synthesis. The evidence base is the category's standard position: preclinical and observational work from a single institute, largely Russian-language; the sources cited in this entry show no ClinicalTrials.gov registration, no independent replication, and no published human pharmacokinetic or controlled efficacy data. The first comprehensive independent functional screen of a peptide from this programme returned a near-null result.
Source
Khavinson programme preclinical publications
Sources
No linked primary source is on file for this entry yet.
Educational use only, never medical advice. No doses.